Recombinant batroxobin (BioBud)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRecombinant batroxobin (BioBud)

Drug Alias NameRec-BBB-Rb1

ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme

Mechanisms of ActionFibrinogen inhibitors

TargetsFibrinogen

Therapy Area/IndicationsBlood Coagulation Disorders

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesBiobud

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesBiobud

Active IndicationsN/A

Inactive IndicationsBlood Coagulation Disorders

ATC CodeN/A